PrEP: Estimating the Cost-Effectiveness Over 40 Years
March 12th 2019Short-term investments in pre-exposure prophylaxis (PrEP) are predicted to result in long-term cost-savings and promote significant health benefits following its distribution in Germany, according to a new modelling study in Eurosurveillance.
Read More